Pharmaceutical companies help anti-doping officials to introduce detection tests for new drugs

Today many drug manufacturers are ready to collaborate with anti-doping officers in their war on intake of forbidden medications in sports. It sounds strange but it is the reality. In fact, if you look at the fate of EPO, you can comprehend why pharmaceutical companies agree to support efforts of anti-doping officials. EPO is actually an efficient remedy for treatment of anemia. Numerous individuals with anemia that have applied EPO have been treated. But what do you think while hearing about this medicine? Almost each person associates this remedy only with doping in sports. This preparation has been abused by the American cyclist Lance Armstrong that has cheated the whole world. Thus, EPO is associated only with cheating, disgrace, etc. Looking at this case, pharmaceutical companies try to “defend” their medicines from the similar fate. That’s why they work together with anti-doping officers.
However several drug manufacturers started to collaborate with anti-doping officials earlier, sometimes there were several problems between them. Anti-doping agencies criticized some drug manufacturers for their connections with doping.
Today relations between anti-doping officers and pharmaceutical companies are better. Drug manufacturers share detailed information about new medications with anti-doping officers. It is valuable information for development of detection tests for these drugs. While anti-doping agencies find out how medications are manufactured, how they pass into body, how they work in the body, they can elaborate more efficient tests for these medications.
For example, the pharmaceutical company Roche that elaborated the preparation CERA helped anti-doping officers to develop a detection test for it. Later other drug manufacturers followed the example of Roche. The company GlaxoSmithKline went so far, as it sponsored an anti-doping lab during London Olympics.
While relations between anti-doping officials and big drug manufacturers become stronger, smaller drug manufacturers begin to collaborate with anti-doping officials as well. While earlier drug manufacturers haven’t desired to discuss about their relations with anti-doping officers publicly, now they don’t fear to announce about this condition.